In this video, hear about some of the latest FDA stories in the life sciences
Hello and welcome to x-talks vitals home to the latest life science medical device and food industry news i’m sonja hunt hear about the latest life science fda news in this video including tighter restrictions on the use of johnson and johnson’s covet 19 vaccine and warning letters sent to companies illegally selling cbd and thc products here’s aisha rashid with some
Of the latest fda updates thank you for the introduction sonia the fda has given out warning letters to five companies selling products labeled as containing a delta eight thc in ways that violate the federal food drug and cosmetic act this is the first time the fda has issued warnings for products containing delta e to thc now delta hthc is similar to the more
Commonly known delta 9 thc which gives users the high effect delta hthc has psychoactive and intoxicating effects that can be dangerous the fda’s warning letters address companies marketing unapproved delta 8 thc products as unapproved treatments for medical conditions or other therapeutic uses in the letters the federal agency also outlined violations related to
Drug misbranding and the addition of delta 8 thc in foods such as chocolate gummies chewing gum and peanut butter among others in covet 19 vaccine news last week the fda placed stricter restrictions on the use of jansen and johnson and johnson’s copic 19 vaccine over concerns of the rare side effect of serious blood clots after administration of the vaccine the
Decision came after the fda conducted an updated analysis evaluation and investigation of reported cases which revealed that the risk of thrombosis with thrombocytopenia syndrome or tts warrants limiting the authorized use of the vaccine overall however the fda maintains that the benefits of the vaccine continue to outweigh any risks associated with the one dose
Shot in individuals 18 years of age and older and the fda’s center for drug evaluation and research or the cder has announced the launch of the accelerating rare disease cures or arc program the goal of the program is to boost the development of safe and effective treatment options for the unmet medical needs of patients with rare diseases the arc program’s mission
Is to drive regulatory and scientific innovation and engagement to speed up the availability of treatments for rare diseases back to you sonya that’s it for today’s show visit xtalks.com for more information on this story and click the link in the description below to find out more about our featured life science webinar for this episode automating and advanced
Genomic sequencing workflow join us again for all your life science medical device and food industry news on xtalks.com and don’t forget to subscribe to the xtalks youtube channel by clicking the subscribe button below and click the notification button to stay tuned for more
Transcribed from video
A Rundown of the Latest FDA Life Science News – May 10/22 By Xtalks Webinars
